Bioorganic & Medicinal Chemistry 2008-10-15

Antioxidant capacity of human blood plasma and human urine: simultaneous evaluation of the ORAC index and ascorbic acid concentration employing pyrogallol red as probe.

P Torres, P Galleguillos, E Lissi, C López-Alarcón

Index: Bioorg. Med. Chem. 16 , 9171-5, (2008)

Full Text: HTML

Abstract

The oxygen radical absorbance capacity (ORAC) methodology has been employed to estimate the antioxidant capacity of human blood plasma and human urine using pyrogallol red (ORAC-PGR) as target molecule. Uric acid, reduced glutathione, human serum albumin, and ascorbic acid (ASC) inhibited the consumption of pyrogallol red, but only ASC generated an induction time. Human blood plasma and human urine protected efficiently pyrogallol red. In these assays, both biological fluids generated neat induction times that were removed by ascorbate oxidase. From these results, ORAC-PGR method could be proposed as a simple alternative to evaluate an ORAC index and, simultaneously, to estimate the concentration of ascorbic acid in human blood plasma or human urine.


Related Compounds

  • Ascorbic acid
  • Glutathione
  • pyrogallol red

Related Articles:

Comparative in vitro study on magnetic iron oxide nanoparticles for MRI tracking of adipose tissue-derived progenitor cells.

2014-01-01

[PLoS ONE 9(9) , e108055, (2014)]

DNA double-strand breaks by Cr(VI) are targeted to euchromatin and cause ATR-dependent phosphorylation of histone H2AX and its ubiquitination.

2015-01-01

[Toxicol. Sci. 143(1) , 54-63, (2014)]

Hypoxia reduces MAX expression in endothelial cells by unproductive splicing.

2014-12-20

[FEBS Lett. 588(24) , 4784-90, (2014)]

Proteolysis of decellularized extracellular matrices results in loss of fibronectin and cell binding activity.

2015-04-03

[Biochem. Biophys. Res. Commun. 459(2) , 246-51, (2015)]

Flow perfusion co-culture of human mesenchymal stem cells and endothelial cells on biodegradable polymer scaffolds.

2014-07-01

[Ann. Biomed. Eng. 42(7) , 1381-90, (2014)]

More Articles...